 Effect continuous-infusion zidovudine therapy neuropsychologic functioning children symptomatic human immunodeficiency virus infection Neuropsychologic function children symptomatic human immunodeficiency virus disease Disease Control Class age months years initiation treatment patients encephalopathy Psychologic tests months continuous-infusion azidothymidine AZT zidovudine treatment months treatment significant increase IQ points general cognitive functioning Follow-up patients months AZT therapy gains IQ points Improvements adaptive behavior months therapy standardized interview findings IQ data significant differences amount change different subgroups magnitude improvements practice effects environmental changes general improvement physical state neuropsychologic function continuous infusion AZT treatment